Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00388-1/abstract?utm_campaign=update-landia&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_landia&_hsenc=p2ANqtz-9oJyYCp4tE7vZ57CGug-8i8ZWC4RO1bwwwzOivGNUyiriF8g_ig6Fd4ejByVSrTgJqlW4_28zeertuM5GEAeI2pisX7Q&_hsmi=296908066&utm_content=296876759&utm_source=hs_email